http://www.healio.com/cardiology/stroke/news/online/%7B7940c895-c29f-4e8a-b183-ac57f5d3f954%7D/video-endovascular-therapy-key-approach-to-improve-time-to-treatment-in-acute-ischemic-stroke?ecp=&dul%3b=&utm_source=maestro&utm_medium=email&utm_campaign=cardiology+news
Gregg Fonarow, MD, professor of cardiovascular medicine at UCLA, discusses the role of endovascular therapy in improving the treatment of patients with acute ischemic stroke, an area of focus at the American Heart Association Scientific Sessions 2015.
Highlighting onset-to-treatment time, Fonarow discusses the clinical outcomes observed with stent retrievers in context of the sole pharmacologic therapy, IV tissue plasminogen activator (tPA), shown to benefit this population.
“Time matters. Time is brain,” he said. “The time for the patient to get to the hospital and the time of arrival to beginning treatment … is critically important in limiting the size of stroke and improving functional recovery.”
Fonarow details “remarkable findings” from the AHA’s Target: Stroke Initiative as well as continued efforts to speed the process from arrival to diagnosis for patients receiving tPA and endovascular therapy.
Finally, he outlines the organized approach needed to achieve outcomes in practice with endovascular therapy including data collection, tracking and national goal-setting.
“We’re beginning the work to capture the valuable data and assemble the teams that will be necessary working together to identify best practices,” Fonarow said. “The time to now speed our therapy for acute ischemic stroke is upon us.”
No comments:
Post a Comment